NCT05997615
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05997615
Title Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Vir Biotechnology, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR | ESP | AUS

Facility Status City State Zip Country Details
Investigational Site Number: 100 RECRUITING Melbourne 3000 Australia Details
Investigational Site Number: 101 RECRUITING Sydney 2010 Australia Details
Investigational Site Number: 251 WITHDRAWN Barcelona 08023 Spain Details
Investigational Site Number: 250 RECRUITING Barcelona 08035 Spain Details
Investigational Site Number: 254 RECRUITING Madrid 28027 Spain Details
Investigational Site Number: 252 RECRUITING Madrid 28223 Spain Details
Investigational Site Number: 253 RECRUITING Pamplona 31008 Spain Details
Investigational Site Number: 300 RECRUITING London SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field